// App-Quantinova.ai

PB2364 : Weight-Adjusted Tinzaparin for Venous Thromboembolism Prophylaxis in Bariatric Surgery Patients Weighing 160kg or More

Researchers

Presenter

  • A. Li

Principal Investigators

  • A. Eshaghpour

  • E.K. Tseng

  • J.D. Douketis

  • M. Anvari

  • M. Tiboni

  • D.M. Siegal

  • R.T. Ikesaka

  • M.A. Crowther

Medical Centers

  • McMaster University Hamilton Health Sciences, Hamilton, ON, Canada

  • McMaster University, Michael G. DeGroote School of Medicine, Hamilton, ON, Canada

  • St. Michael's Hospital, Hematology and Oncology, Toronto, Canada

  • University of Alberta, Department of Paediatrics, Edmonton, Canada

  • McMaster University, Internal Medicine, Hamilton, Canada

  • St. Joseph's Healthcare Hamilton, Department of Surgery, Hamilton, Canada

  • Population Health Research Institute, Hamilton, Canada

  • St. Joseph's Healthcare Hamilton, Hamilton, Division of Hematology, Hamilton, Canada

  • The Ottawa Hospital, Nursing, Ottawa, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Tinzaparin

  • Heparin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved